These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2413153)

  • 1. Decay-accelerating factor is present on paroxysmal nocturnal hemoglobinuria erythroid progenitors and lost during erythropoiesis in vitro.
    Moore JG; Frank MM; Müller-Eberhard HJ; Young NS
    J Exp Med; 1985 Oct; 162(4):1182-92. PubMed ID: 2413153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of decay-accelerating factor on hematopoietic progenitors and their progeny cells grown in cultures with fractionated bone marrow cells from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Okuda K; Kanamaru A; Ueda E; Kitani T; Okada N; Okada H; Kakishita E; Nagai K
    Exp Hematol; 1990 Nov; 18(10):1132-6. PubMed ID: 1698649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different distribution of decay-accelerating factor on hematopoietic progenitors from normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Kanamaru A; Okuda K; Ueda E; Kitani T; Kinoshita T; Nagai K
    Blood; 1988 Aug; 72(2):507-11. PubMed ID: 2456796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Medof ME; Silber R; Nussenzweig V
    J Exp Med; 1985 Jul; 162(1):75-92. PubMed ID: 2409211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the hematopoietic defect in paroxysmal nocturnal hemoglobinuria.
    Moore JG; Humphries RK; Frank MM; Young N
    Exp Hematol; 1986 Mar; 14(3):222-9. PubMed ID: 3512279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum.
    Wilcox LA; Ezzell JL; Bernshaw NJ; Parker CJ
    Blood; 1991 Aug; 78(3):820-9. PubMed ID: 1713516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes.
    Medof ME; Gottlieb A; Kinoshita T; Hall S; Silber R; Nussenzweig V; Rosse WF
    J Clin Invest; 1987 Jul; 80(1):165-74. PubMed ID: 2439544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
    Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amelioration of lytic abnormalities of paroxysmal nocturnal hemoglobinuria with decay-accelerating factor.
    Medof ME; Kinoshita T; Silber R; Nussenzweig V
    Proc Natl Acad Sci U S A; 1985 May; 82(9):2980-4. PubMed ID: 2581259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunocytochemical staining of decay-accelerating factor (DAF) on erythrocytes: paroxysmal nocturnal hemoglobinuria (PNH)].
    Kobayashi T; Nakazawa M; Sato Y; Tomiyama J; Ninomiya H; Abe T; Terasawa T; Shichishima T; Fujita T
    Rinsho Ketsueki; 1992 Feb; 33(2):162-6. PubMed ID: 1378912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.
    Nicholson-Weller A; March JP; Rosenfeld SI; Austen KF
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5066-70. PubMed ID: 6576376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The population of paroxysmal nocturnal hemoglobinuria neutrophils deficient in decay-accelerating factor is also deficient in alkaline phosphatase.
    Burroughs SF; Devine DV; Browne G; Kaplan ME
    Blood; 1988 Apr; 71(4):1086-9. PubMed ID: 2451546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decay-accelerating factor (DAF) on the blood cell membranes in patients with paroxysmal nocturnal haemoglobinuria (PNH): measurement by enzyme-linked immunosorbent assay (ELISA).
    Ninomiya H; Abe T; Shichishima T; Terasawa T; Fujita T
    Br J Haematol; 1988 May; 69(1):81-7. PubMed ID: 2454648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The erythrocytes in paroxysmal nocturnal haemoglobinuria of intermediate sensitivity to complement lysis.
    Rosse WF; Hoffman S; Campbell M; Borowitz M; Moore JO; Parker CJ
    Br J Haematol; 1991 Sep; 79(1):99-107. PubMed ID: 1716964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5430-4. PubMed ID: 6225118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective and normal haematopoietic stem cells in paroxysmal nocturnal haemoglobinuria.
    Terstappen LW; Nguyen M; Huang S; Lazarus HM; Medof ME
    Br J Haematol; 1993 Jul; 84(3):504-14. PubMed ID: 7692931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longer in vivo survival of CD59- and decay-accelerating factor-almost normal positive and partly positive erythrocytes in paroxysmal nocturnal hemoglobinuria as compared with negative erythrocytes: a demonstration by differential centrifugation and flow cytometry.
    Fujioka S; Yamada T
    Blood; 1992 Apr; 79(7):1842-5. PubMed ID: 1373090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement sensitivity of erythroblasts and erythropoietic precursors in paroxysmal nocturnal haemoglobinuria (PNH).
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Br J Haematol; 1989 Aug; 72(4):578-83. PubMed ID: 2775661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Markedly high population of affected reticulocytes negative for decay-accelerating factor and CD59 in paroxysmal nocturnal hemoglobinuria.
    Iwamoto N; Kawaguchi T; Nagakura S; Hidaka M; Horikawa K; Kagimoto T; Takatsuki K; Nakakuma H
    Blood; 1995 Apr; 85(8):2228-32. PubMed ID: 7536494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.